TONGLI PHARMACEUTICALS (USA), INC.: 10-Q filed 2013-02-14

Name: TONGLI PHARMACEUTICALS (USA), INC.: 10-Q filed 2013-02-14
Creator: TONGLI PHARMACEUTICALS (USA), INC.

What TONGLI PHARMACEUTICALS (USA), INC. reported in its quarterly report filed 2013-02-14 (fiscal Q3 2012): 37 published measures, 94 facts as tagged in accession 0001144204-13-008567.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-02-14
Fiscal period: fiscal Q3 2012
Accession: 0001144204-13-008567 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TONGLI PHARMACEUTICALS (USA), INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-12-31	21,638,881	USD
At 2012-03-31	19,841,675	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-12-31	20,463,470	USD
At 2012-03-31	18,340,832	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,315,116	USD	92
2012-04-01 to 2012-12-31	1,633,798	USD	275
2011-10-01 to 2011-12-31	1,264,046	USD	92
2011-04-01 to 2011-12-31	3,201,717	USD	275

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	4,710,954	USD	275
2011-04-01 to 2011-12-31	-425,390	USD	275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	0	USD	275
2011-04-01 to 2011-12-31	857	USD	275

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	276,645	USD	275
2011-04-01 to 2011-12-31	-1,169,990	USD	275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	-4,929,187	USD	275
2011-04-01 to 2011-12-31	1,094,824	USD	275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2012-12-31	9,042,661	USD
At 2012-03-31	7,408,863	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	468,508	USD	92
2012-04-01 to 2012-12-31	684,240	USD	275
2011-10-01 to 2011-12-31	468,896	USD	92
2011-04-01 to 2011-12-31	1,449,260	USD	275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-12-31	6,009,458	USD
At 2012-03-31	6,193,526	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	215,000	USD	275
2011-04-01 to 2011-12-31	813,821	USD	275

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,793,646	USD	92
2012-04-01 to 2012-12-31	2,327,797	USD	275
2011-10-01 to 2011-12-31	1,732,942	USD	92
2011-04-01 to 2011-12-31	4,678,858	USD	275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-12-31	4,354,332	USD
At 2012-03-31	9,137,391	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-551	USD	92
2012-04-01 to 2012-12-31	-814	USD	275
2011-10-01 to 2011-12-31	0	USD	92
2011-04-01 to 2011-12-31	27,881	USD	275

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-12-31	1,175,411	USD
At 2012-03-31	1,500,843	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-12-31	118,111	USD
At 2012-03-31	429,117	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2012-12-31	5,252,333	USD
At 2012-03-31	4,041,032	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-12-31	2,473,443	USD
At 2012-03-31	4,166,178	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	226,227	USD	92
2012-04-01 to 2012-12-31	1,275,158	USD	275
2011-10-01 to 2011-12-31	310,701	USD	92
2011-04-01 to 2011-12-31	1,728,171	USD	275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-12-31	98,518	USD
At 2012-03-31	13,613	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	2,019,873	USD	92
2012-04-01 to 2012-12-31	3,602,955	USD	275
2011-10-01 to 2011-12-31	2,043,643	USD	92
2011-04-01 to 2011-12-31	6,407,029	USD	275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-12-31	14,728,111	shares
At 2012-03-31	13,294,778	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2012-12-31	9,056,266	USD
At 2012-03-31	8,842,699	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-12-31	2,349,815	USD
At 2012-03-31	2,075,975	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-12-31	192,489	USD
At 2012-03-31	192,340	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2012-12-31	43,552	USD
At 2012-03-31	241,738	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	1,386,033	USD	92
2012-04-01 to 2012-12-31	1,907,639	USD	275
2011-10-01 to 2011-12-31	1,374,237	USD	92
2011-04-01 to 2011-12-31	3,790,409	USD	275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	130,494	USD	92
2012-04-01 to 2012-12-31	764,209	USD	275
2011-10-01 to 2011-12-31	181,906	USD	92
2011-04-01 to 2011-12-31	1,324,849	USD	275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	460,420	USD	275
2011-04-01 to 2011-12-31	419,622	USD	275

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	197,633	USD	275
2011-04-01 to 2011-12-31	158,148	USD	275

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	15,860	USD	92
2012-04-01 to 2012-12-31	15,860	USD	275
2011-10-01 to 2011-12-31	0	USD	92
2011-04-01 to 2011-12-31	0	USD	275

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-10,022	USD	92
2012-04-01 to 2012-12-31	-9,759	USD	275
2011-10-01 to 2011-12-31	0	USD	92
2011-04-01 to 2011-12-31	-27,881	USD	275

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	376,159	USD	275
2011-04-01 to 2011-12-31	1,451,960	USD	275

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	308,081	USD	275
2011-04-01 to 2011-12-31	-2,143	USD	275

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	-1,748,166	USD	275
2011-04-01 to 2011-12-31	1,623,358	USD	275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	84,677	USD	275
2011-04-01 to 2011-12-31	2,445,052	USD	275

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2012-04-01 to 2012-12-31	-316,626	USD	275
2011-04-01 to 2011-12-31	-649,891	USD	275

Inspect the source

Entity: TONGLI PHARMACEUTICALS (USA), INC. / CIK 0001052284
Captured: 2026-09-22 19:37 UTC
SEC response SHA-256: cecbc5501de9187b88864fce4f9988916aa157e54132bd604a9d0b3d020861a9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001052284.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))